As of 2025-11-18, the EV/EBITDA ratio of Theraclion SA (ALTHE.PA) is -5.64. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ALTHE.PA's latest enterprise value is 32.87 mil EUR. ALTHE.PA's TTM EBITDA according to its financial statements is -5.82 mil EUR. Dividing these 2 quantities gives us the above ALTHE.PA EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 4.8x - 11.0x | 7.5x |
| Forward P/E multiples | 7.1x - 11.2x | 9.4x |
| Fair Price | (0.90) - (1.38) | (1.07) |
| Upside | -231.9% - -303.6% | -256.9% |
| Date | EV/EBITDA |
| 2025-11-17 | -5.64 |
| 2025-11-14 | -5.63 |
| 2025-11-13 | -5.50 |
| 2025-11-12 | -5.71 |
| 2025-11-11 | -5.29 |
| 2025-11-10 | -5.39 |
| 2025-11-07 | -5.56 |
| 2025-11-06 | -5.85 |
| 2025-11-05 | -5.89 |
| 2025-11-04 | -6.13 |
| 2025-11-03 | -5.40 |
| 2025-10-31 | -4.87 |
| 2025-10-30 | -4.89 |
| 2025-10-29 | -4.92 |
| 2025-10-28 | -5.13 |
| 2025-10-27 | -5.48 |
| 2025-10-24 | -5.64 |
| 2025-10-23 | -5.27 |
| 2025-10-22 | -5.64 |
| 2025-10-21 | -4.82 |
| 2025-10-20 | -4.87 |
| 2025-10-17 | -5.05 |
| 2025-10-16 | -5.19 |
| 2025-10-15 | -5.27 |
| 2025-10-14 | -5.45 |
| 2025-10-13 | -5.08 |
| 2025-10-10 | -5.05 |
| 2025-10-09 | -5.24 |
| 2025-10-08 | -5.39 |
| 2025-10-07 | -5.64 |
| 2025-10-06 | -5.56 |
| 2025-10-03 | -6.08 |
| 2025-10-02 | -5.94 |
| 2025-10-01 | -6.13 |
| 2025-09-30 | -6.05 |
| 2025-09-29 | -6.13 |
| 2025-09-26 | -6.37 |
| 2025-09-25 | -7.05 |
| 2025-09-24 | -6.86 |
| 2025-09-23 | -6.79 |
| 2025-09-22 | -7.02 |
| 2025-09-19 | -6.91 |
| 2025-09-18 | -7.03 |
| 2025-09-17 | -7.02 |
| 2025-09-16 | -6.99 |
| 2025-09-15 | -7.05 |
| 2025-09-12 | -5.81 |
| 2025-09-11 | -5.81 |
| 2025-09-10 | -5.95 |
| 2025-09-09 | -6.18 |